AS
Ascletis Pharma Inc.
ASCLF · OTC
$1.20 -0.83% (-$0.01)
1M -7.69%
Market Cap ¥8.42B
P/E Ratio -
Div. Yield -
ROE 17.44%
Piotroski F-Score Weak
1/9Valuation
23 /100
Expensive P/B 4.35x
P/S 4,263.77x
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 8.66%
Rev. growth 66.82%
FCF growth N/A
Profitability
0 /100
Weak Net margin 17,745.60%
Op. margin 23,854.00%
FCF margin 16,746.40%
Quality
0 /100
Poor ROE 17.44%
ROA 16.96%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 15.05x
Int. coverage -2,949.78x
Debt/Equity 0.00x
Stability
13 /100
Unstable Rev. volatility 77.39%
EPS volatility 93.54%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ASCLF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jinzi J. Wu
Employees
202
Headquarters
Hangzhou
Prihajajoči dogodki
30 MAR.
Earnings
Upcoming earnings report